With the global aging, the incidence of degenerative diseases is increasing. Parkinson's disease, spinal cord injury and other neurodegenerative diseases all involve the irreversible loss of certain types of neural cells, which can be addressed by regenerative medicine based largely on cutting-edge stem cell technology. With our directed differentiation platform, we can derive authentic  functional neural cells from pluripotent stem cells to replace damaged cells and restore neurotransmitter level, rebuild neural network,and improve quality of life.

UniXell has developed an integrated platform consisting of somatic cell reprogramming technology, stem cell in vitro differentiation technology, high-precision gene editing facility and propriotary SISBAR lineage tracing tool. This platform facilitates efficient generation of pluripotent stem cells and optimization of in vitro differentiation of target cells, enables to manufacture high purity and high standard of cell therapy products and eventually ensure to achieve a stable, high-efficient and safe clinical therapeutic outcomes.

Life begins as a single cell and pluripotent stem cells that replicate indefinitely make it possible to redefine life. The people of Unixell will work together tirelessly and pursue the truth endlessly, creat the sharp spear to fight the diseases and forges the strong shield to aganist the aging, then realize the dream of a healthy life for human beings.